全文获取类型
收费全文 | 4496篇 |
免费 | 408篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 148篇 |
妇产科学 | 100篇 |
基础医学 | 624篇 |
口腔科学 | 85篇 |
临床医学 | 379篇 |
内科学 | 987篇 |
皮肤病学 | 191篇 |
神经病学 | 423篇 |
特种医学 | 124篇 |
外科学 | 776篇 |
综合类 | 31篇 |
预防医学 | 401篇 |
眼科学 | 61篇 |
药学 | 261篇 |
中国医学 | 6篇 |
肿瘤学 | 277篇 |
出版年
2023年 | 32篇 |
2022年 | 39篇 |
2021年 | 131篇 |
2020年 | 74篇 |
2019年 | 122篇 |
2018年 | 146篇 |
2017年 | 101篇 |
2016年 | 100篇 |
2015年 | 117篇 |
2014年 | 166篇 |
2013年 | 194篇 |
2012年 | 271篇 |
2011年 | 269篇 |
2010年 | 146篇 |
2009年 | 137篇 |
2008年 | 207篇 |
2007年 | 216篇 |
2006年 | 200篇 |
2005年 | 216篇 |
2004年 | 186篇 |
2003年 | 190篇 |
2002年 | 163篇 |
2001年 | 139篇 |
2000年 | 132篇 |
1999年 | 113篇 |
1998年 | 55篇 |
1997年 | 44篇 |
1996年 | 42篇 |
1995年 | 38篇 |
1994年 | 50篇 |
1993年 | 35篇 |
1992年 | 82篇 |
1991年 | 89篇 |
1990年 | 75篇 |
1989年 | 69篇 |
1988年 | 67篇 |
1987年 | 69篇 |
1986年 | 57篇 |
1985年 | 57篇 |
1984年 | 42篇 |
1983年 | 32篇 |
1982年 | 20篇 |
1981年 | 22篇 |
1980年 | 14篇 |
1979年 | 23篇 |
1978年 | 17篇 |
1977年 | 16篇 |
1976年 | 13篇 |
1975年 | 13篇 |
1972年 | 17篇 |
排序方式: 共有4927条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
6.
The effects of sulfated cholecystokinin (CCK-8S) and glucose on insulin secretion and polyphosphoinositide (PPI) metabolism were studied in isolated rat islets. Both agonists stimulate PPI hydrolysis, inositol phosphate accumulation, 3H efflux from [3H]inositol-prelabeled tissue, and 45Ca efflux from prelabeled cells. However, the effects of CCK-8S on PPI metabolism are considerably greater than those of glucose. Furthermore, the effects of CCK-8S on PPI and Ca2+ metabolism are observed whether islets are incubated in either 2.75 or 7 mM glucose, but CCK-8S only stimulates insulin secretion (a biphasic response) when the higher glucose concentration is present. Addition of 1 microM forskolin to islets incubated in media containing 2.75 mM glucose does not influence basal insulin secretion but sensitizes the islets to the action of CCK-8S. In the presence of forskolin, CCK-8S induces a very marked first phase but no second phase of insulin secretion. We postulate that CCK-8S acts in this tissue via receptor-linked PPI hydrolysis, leading to an inositol trisphosphate-induced Ca2+ efflux. These receptor-mediated effects of CCK-8S are not altered either by the ambient glucose concentration or the cAMP content of the islets, but these two factors determine the responsiveness of the islets (in terms of insulin secretion) to a given CCK-8S signal. 相似文献
7.
E Moreno González I Landa Garcia J Calleja Kempin M Gomez Gutierrez J Arias Diaz D Riano Carrera F Parez Cerda P Moral Gutierrez F Guillen Ramirez I Garcia Garcia 《Der Chirurg》1990,61(10):701-704
Between 4/1986 to 1/1989, 74 orthotopic liver transplantation were performed in 62 patients (62 first liver transplants, 10 as second graft and two as a third graft); 57 in adults and 17 in children. The main indication for the operation was liver cirrhosis (61.4%) (the most frequent etiology was alcoholic cirrhosis, 28.5%). Six cirrhotic patients had a hepatocarcinoma (9.6%). Two received a liver and kidney transplant due to terminal renal insufficiency and hemodialysis. The most frequent indication in children was biliary atresia (33.3%). Six patients had a fulminal liver failure (9.6%). AB0 blood group compatibility was identical in 87.5%, compatible in six and incompatible in three patients. Total orthotopic liver transplantation was performed in 67 patients, and size-reduced liver was indicated in 7 patients. Extracorporeal veno-venous bypass was used in adults but never in children. In 93.1% of the transplants a single hepatic artery was anastomosed to the recipient and in 6.9% a double anastomosis was performed. In 62.5% of the patients a end-to-end choledocho-choledochostomy was performed and in 34.8% hepatico-jejunostomy was indicated. Three months postoperative mortality rate was 12.9%. Arterial stenosis and thrombosis were the most frequent complication. 相似文献
8.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
9.
10.